These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2260042)

  • 21. [Porphyria--a pharmacogenetic disease].
    Kostrzewska E; Gregor A
    Wiad Lek; 1986 Dec; 39(24):1713-7. PubMed ID: 3577184
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatitis, cholestasis and amineptine (author's transl)].
    Bel A; Girard D
    Sem Hop; 1981 Dec 18-25; 57(47-48):1992-6. PubMed ID: 6276980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biochemical mechanisms of the hepatotoxicity of psychotropic drugs].
    Dostert P; Benedetti MS
    Encephale; 1984; 10(5):199-209. PubMed ID: 6151491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Peroral hymecromone treatment of female patients under long term therapy with psychopharmaceuticals].
    Petrioli G
    Fortschr Med; 1979 Jul; 97(25-26):1174-8. PubMed ID: 378799
    [No Abstract]   [Full Text] [Related]  

  • 25. [Silymarin in the prevention of hepatic damage by psychopharmacologic drugs. Experimental premises and clinical evaluations].
    Carrescia O; Benelli L; Saraceni F; Braga PC; Cagnetta G; Copponi V
    Clin Ter; 1980 Oct; 95(2):157-64. PubMed ID: 7471652
    [No Abstract]   [Full Text] [Related]  

  • 26. [Atrium-related hepatitis. Report of four cases].
    Horsmans Y; Larrey D; Pessayre D; Rueff B; Degott C; Benhamou JP
    Gastroenterol Clin Biol; 1991; 15(8-9):648-52. PubMed ID: 1684328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The problem of poly-pharmacotherapy in patients on a mephedrone binge.
    Ordak M; Nasierowski T; Muszynska E
    Pharmacol Res; 2019 May; 143():204. PubMed ID: 30951811
    [No Abstract]   [Full Text] [Related]  

  • 28. [Controlled clinical evaluation of cicloxilic acid in hepatopathies caused by psychopharmacological agents].
    Bocci U; Beretta G
    Clin Ter; 1980 May; 93(4):373-88. PubMed ID: 6998639
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug-induced hepatitis. Local monitoring criteria].
    Rossini L; Leone L
    Minerva Med; 1980 Nov; 71(47):3455-61. PubMed ID: 6161323
    [No Abstract]   [Full Text] [Related]  

  • 30. [Valproic acid derivatives: toxicity and adverse effects].
    Kłosiewicz L; Puzyński S
    Psychiatr Pol; 1987; 21(1):57-61. PubMed ID: 3112824
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biochemico-etiopathogenic correlation in 26 cases of hepatopathy caused by drugs].
    Lozano Gutíerrez F; Saenz de Santa María FJ; Soria Monge A; Jimena Medina M; Pérez Miranda M
    Rev Esp Enferm Apar Dig; 1984 Feb; 65(2):147-56. PubMed ID: 6610903
    [No Abstract]   [Full Text] [Related]  

  • 32. [Analysis of liver function tests, blood lipids and blood glucose levels in 84 patients treated with psychopharmacologic agents for prolonged periods].
    Cordella L; Lazzari D; Passanisi S; Cocchi R
    Riv Neurobiol; 1980; 26(3):291-302. PubMed ID: 7336077
    [No Abstract]   [Full Text] [Related]  

  • 33. Severe and life-threatening adverse reactions to psychotropic drugs.
    Spiess-Kiefer C; Grohmann R; Schmidt LG; Rüther E
    Pharmacopsychiatry; 1988 Nov; 21(6):290-2. PubMed ID: 3244756
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug-induced liver diseases].
    Manenti F; Ferrari A
    G Clin Med; 1989 Dec; 70(12):723-32. PubMed ID: 2612805
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatotoxicity of drugs. Update of a data bank of hepatic involvements and responsible drugs].
    Biour M; Poupon R; Calmus Y; Grangé JD; Hamel JD; Lévy VG; Bodin F; Cheymol G
    Gastroenterol Clin Biol; 1988 Jan; 12(1):48-60. PubMed ID: 3350250
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hepatic toxicity of new antidepressive drugs. Apropos of a case].
    Zarski JP; Aubert H; Rachail M
    Gastroenterol Clin Biol; 1983 Feb; 7(2):220-1. PubMed ID: 6840468
    [No Abstract]   [Full Text] [Related]  

  • 37. Psychopharmacological profile of the new cognition enhancing agent exifone in the mouse.
    Porsolt RD; Lenègre A; Avril I; Lancrenon S; Stéru L; Doumont G
    Arzneimittelforschung; 1987 Apr; 37(4):388-93. PubMed ID: 2886129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fulminant hepatic necrosis following halothane anesthesia.
    Rivera RA; McAllister HA; Robinowitz M
    Med Ann Dist Columbia; 1970 Jul; 39(7):372-3. PubMed ID: 5268880
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluothane (halothane) anesthesia and acute hepatic toxicity.
    Bhoopathi B; Ostapowicz F; Del Rosario L
    Mo Med; 1974 Oct; 71(10):581-3 passim. PubMed ID: 4444712
    [No Abstract]   [Full Text] [Related]  

  • 40. [Acute hepatitis caused by dihydralazine].
    Boccaccio F; Attali P; Nataf J; Ink O; Fabre M; Pelletier G
    Gastroenterol Clin Biol; 1987; 11(8-9):614. PubMed ID: 3653625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.